pcDNA3-HA-Uch37 Citations (5)

Originally described in: Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.
Yao T, Song L, Xu W, DeMartino GN, Florens L, Swanson SK, Washburn MP, Conaway RC, Conaway JW, Cohen RE Nat Cell Biol. 2006 Sep . 8(9):994-1002. PubMed Journal

---

Articles Citing pcDNA3-HA-Uch37

Articles
Regulation of E2 promoter binding factor 1 (E2F1) transcriptional activity through a deubiquitinating enzyme, UCH37. Mahanic CS, Budhavarapu V, Graves JD, Li G, Lin WC. J Biol Chem. 2015 Oct 30;290(44):26508-22. doi: 10.1074/jbc.M115.659425. Epub 2015 Sep 22. PubMed
Aging Triggers Cytoplasmic Depletion and Nuclear Translocation of the E3 Ligase Mahogunin: A Function for Ubiquitin in Neuronal Survival. Benvegnu S, Mateo MI, Palomer E, Jurado-Arjona J, Dotti CG. Mol Cell. 2017 May 4;66(3):358-372.e7. doi: 10.1016/j.molcel.2017.04.005. PubMed
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1. Daou S, Barbour H, Ahmed O, Masclef L, Baril C, Sen Nkwe N, Tchelougou D, Uriarte M, Bonneil E, Ceccarelli D, Mashtalir N, Tanji M, Masson JY, Thibault P, Sicheri F, Yang H, Carbone M, Therrien M, Affar EB. Nat Commun. 2018 Oct 22;9(1):4385. doi: 10.1038/s41467-018-06854-2. PubMed
HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1. Santos-Barriopedro I, Li Y, Bahl S, Seto E. Genes Cancer. 2019;10(5-6):119-133. doi: 10.18632/genesandcancer.197. PubMed
Inhibiting UCH-L5: Rational Design of a Cyclic Ubiquitin-Based Peptide Inhibitor. Hameed DS, Ovaa H, van der Heden van Noort GJ, Sapmaz A. Front Mol Biosci. 2022 May 26;9:866467. doi: 10.3389/fmolb.2022.866467. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.